OctoPlus N.V. : OctoPlus' Annual General Meeting of shareholders will be held
on 28 June
Leiden, the Netherlands, 13 June 2013 - OctoPlus N.V. ("OctoPlus" or the
"Company") announces that its Annual General Meeting of Shareholders will be
held at the Company's headquarters in Leiden on 28 June 2013 at 10 AM CET. The
agenda and explanatory notes thereto are available in the Corporate
Information section on the Company's website, www.octoplus.nl. A printed copy
of the Annual Report 2012 can be obtained free of charge at the office address
of the Company or via e-mail to firstname.lastname@example.org.
For further information, please contact:
Investor relations: telephone number +31 (71) 524 1061, or send an e-mail to
Investor Relations at email@example.com.
OctoPlus is a leading European provider of advanced drug formulation and
clinical scale manufacturing services to the pharmaceutical and biotechnology
industries, with a focus on difficult to formulate active pharmaceutical
ingredients. For more information about OctoPlus, please visit our website
In addition, OctoPlus is a specialty pharmaceutical company focused on the
development and manufacture of improved injectable pharmaceuticals based on
our proprietary drug delivery technologies that exhibit fewer side effects,
improved patient convenience and a better efficacy/safety balance than
existing therapies. OctoPlus also focuses on the development of long-acting,
controlled release versions of known protein therapeutics, peptides and small
molecules, including specialty generics.
This document may contain certain forward-looking statements relating to the
business, financial performance and results of OctoPlus and the industry in
which it operates. These statements are based on OctoPlus' current plans,
estimates and projections, as well as its expectations of external conditions
and events. In particular the words "expect", "anticipate", "predict",
"estimate", "project", "plan", "may", "should", "would", "will", "intend",
"believe" and similar expressions are intended to identify forward-looking
statements. We caution investors that a number of important factors, and the
inherent risks and uncertainties that such statements involve, could cause
actual results or outcomes to differ materially from those expressed in any
forward-looking statements. In the event of any inconsistency between an
English version and a Dutch version of this document, the English version will
prevail over the Dutch version.
Click here for the press release in PDF
This announcement is distributed by Thomson Reuters on behalf of Thomson
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.
Source: OctoPlus N.V. via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.